TY  - GEN
AU  - Mitsias,P D
AU  - Lu,M
AU  - Silver,B
AU  - Morris,D
AU  - Ewing,J R
AU  - Daley,S
AU  - Lewandowski,C
AU  - Katramados,A
AU  - Papamitsakis,N I
AU  - Ebadian,H B
AU  - Zhao,Q
AU  - Soltanian-Zadeh,H
AU  - Hearshen,D
AU  - Patel,S C
AU  - Chopp,M
TI  - MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
SN  - 1526-632X
PY  - 2006///0123
KW  - Abciximab
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Anticoagulants
KW  - Brain
KW  - drug effects
KW  - Brain Ischemia
KW  - diagnosis
KW  - Cerebral Arteries
KW  - Female
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Infusions, Intravenous
KW  - Intracranial Hemorrhages
KW  - chemically induced
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Patient Selection
KW  - Stroke
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1212/01.wnl.0000172862.33641.92
ER  -